Table 1.
DV group (n = 43) |
Control group (n = 25) |
P value | |
---|---|---|---|
Age | 54.0 ± 14.1 | 60.5 ± 10.6 | 0.069 |
IPSS-V | 9.1 ± 7.2 | 1.4 ± 1.6 | < 0.001 |
IPSS-S | 6.0 ± 4.0 | 2.5 ± 2.0 | 0.001 |
IPSS | 15.1 ± 9.9 | 3.9 ± 2.2 | < 0.001 |
VUDS | |||
FSF | 127.1 ± 54.4 | 164.6 ± 65.3 | 0.012 |
Bladder compliance | 77.6 ± 84.1 | 158.1 ± 93.7 | < 0.001 |
CBC | 290.3 ± 125.6 | 379.0 ± 179.0 | 0.004 |
Pdet | 47.79 ± 42.74 | 14.62 ± 7.19 | 0.001 |
Qmax | 10.66 ± 6.85 | 19.41 ± 8.64 | < 0.001 |
cQmax | 0.63 ± 0.37 | 0.91 ± 0.39 | < 0.001 |
Vol | 232.7 ± 114.2 | 406.3 ± 143.7 | < 0.001 |
PVR | 57.7 ± 66.2 | 5.7 ± 12.4 | < 0.001 |
VE | 0.79 ± 0.23 | 0.98 ± 0.05 | < 0.001 |
BOOIf | 24.33 ± 47.82 | − 30.41 ± 18.16 | < 0.001 |
DV Dysfunctional voiding, IPSS International prostate symptom score, IPSS-S International prostate symptom score storage subscore, IPSS-V International prostate symptom score voiding subscore, VUDS Videourodynamic study, FSF First sensation of bladder filling, CBC Cystometric bladder capacity, Pdet Detrusor voiding pressure, Qmax Maximal urinary flow rate, cQmax Corrected maximal urinary flow rate, Vol Voided volume, PVR Post-void residual volume, VE Voiding efficacy, BOOIf Female bladder outlet obstruction index.